Contineum Therapeutics In... (CTNM)
NASDAQ: CTNM
· Real-Time Price · USD
12.24
-0.28 (-2.24%)
At close: Sep 10, 2025, 2:07 PM
Contineum Therapeutics Class A Common Stock Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for CTNM stock have an median target of 22, with a low estimate of 16 and a high estimate of 31. The median target predicts an increase of 79.74% from the current stock price of 12.24.
| Target | Low | Average | Median | High |
|---|---|---|---|---|
| Price | 16 | 22.75 | 22 | 31 |
| Change | 30.72% | 85.87% | 79.74% | 153.27% |
Latest Analyst Insight Report
RBC Capital maintains an Outperform rating on Cont... Unlock content with Pro Subscription
Updated May 15, 2025
| Rating | Oct 24 | Nov 24 | Jan 25 | Mar 25 | May 25 | Aug 25 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 1 | 1 | 1 | 2 | 2 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 1 | 2 | 2 | 1 |
Financial Forecast this Year
Revenue This Year
5M
from 0
Increased by n/a%
Revenue Next Year
0
from 5M
Increased by -100%
EPS This Year
-2.31
from -2.18
Increased by -6%
EPS Next Year
-2.7
from -2.31
Increased by -16.9%